FGEN•benzinga•
FibroGen Announces Publication Of Results From Phase 1 Monotherapy Study Of FG-3246 In Patients With Metastatic Castration-Resistant Prostate Cancer In Journal of Clinical Oncology; Says Initiation Of Phase 2 Monotherapy Dose Optimization Study Of FG-3246
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 28, 2025 by benzinga